Loading...
Deubiquitinating Enzyme: A Potential Secondary Checkpoint of Cancer Immunity
The efficacy of cancer immunotherapy depends on the fine interplay between tumoral immune checkpoints and host immune system. However, the up-to-date clinical performance of checkpoint blockers in cancer therapy revealed that higher-level regulation should be further investigated for better therapeu...
Saved in:
| Published in: | Front Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7426525/ https://ncbi.nlm.nih.gov/pubmed/32850399 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01289 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|